SENEXON
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Effective date
- 2018-05-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:54:16
Label at a glance#
ProductSENEXON
Active ingredientSENNOSIDES A and B
Label structure14 sections
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet) Sennosides 8.6mg
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you are taking any other drug. Take this product tow or more hours before or after other drugs. Laxatives may affect how other drugs work.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have noticed a sudden change in bowel habits that lasts over two weeks.
WARNINGS SECTION
Do not use for longer than one week, when abdominal pain, nausea or vomiting are present.
OTC - STOP USE SECTION
Stop use and ask a doctor if: you have rectal bleeding; you fail to have a bowel movement after use of this product. These may indicate a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - PURPOSE SECTION
uses
relieves occasional constipation(irregularity);generally causes bowel movement in 6-12 hours.
OTC - QUESTIONS SECTION
1800 645-2158 9 am - 5 pm Monday - Friday
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
INACTIVE INGREDIENT SECTION
Inactive Ingredients croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, minerol oil
DOSAGE & ADMINISTRATION SECTION
Dosage and Administration
Adults and children 12 years and over - 2 tablets once a day - maximum dosage - 4 tablets twice a day
Children 6 to under 12 years - 1 tablet once a day maximum dosage - 2 tablets twice a day
children 2 to under 6 years - 1/2 tablet once a day - maximum dosage - 1 tablet twice a day
INDICATIONS & USAGE SECTION
Relieves occasional constipation
Generally produces bowel movement in 6-12 hours
Repackaging Information
Please reference the How Supplied section listed above for a description of individual tablets. This drug product has been received by Aphena Pharma - TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
| Count | 8.6 mg |
| 100 | 71610-058-65 |
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
Cookeville, TN 38506
20180514JH
PRINCIPAL DISPLAY PANEL - 8.6 mg
NDC 71610-058 - Sennosides (Senna) 8.6 mg
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71610-058-65 | EA - Each | 71610-058 | 3635cafc-b9e2-44c2-972c-5c0a351ef8b5 | 1 | 2018-09-05 |
| 0536-5904-01 | EA - Each | 0536-5904 | 84126d7e-b826-4446-a769-84be30acc725 | 1 | 2012-07-24 |
| 0536-5904-10 | EA - Each | 0536-5904 | 6d31bad8-e482-4476-87f4-35cc06ef188a | 1 | 2012-07-24 |
Products#
Every source-derived product name is available through these pages.
- SENEXON
- SENNA
- SENNOSIDES A and B
- CROSCARMELLOSE SODIUM
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- HYPROMELLOSE 2910 (6 MPA.S)
- magnesium stearate
- CELLULOSE, MICROCRYSTALLINE
- mineral oil
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 71610-058 | 71610-058-65 |
| 0536-5904 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES A and B | 1B5FPI42EN | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSE 2910 (6 MPA.S) | 0WZ8WG20P6 | IACT |
| magnesium stearate | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| mineral oil | T5L8T28FGP | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 73cf2c07-fa54-4859-8d5b-4117ecb94bc6 | 18c77552-9e65-4e73-9e41-59f91075ce94 | 2025-05-29 | Warnings | 18c77552-9e65-4e73-9e41-59f91075ce94 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.